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A new human gene complex encoding the killer cell inhibitory
receptors and related monocyte/macrophage receptors
N. Wagtmann*, S. Rojo*, E. Eichler†, H. Mohrenweiser† and E.O. Long*
Activation of various immune cell types can be
prevented by negative signaling receptors. Natural killer
(NK) cells, which can lyse tumor or virus-infected cells,
express inhibitory receptors that recognise distinct ‘self’
class I molecules of the major histocompatibility
complex [1]. Recognition of self class I molecules
results in a negative signal to prevent NK-mediated
killing of healthy cells [2]. Human and mouse NK cells
express both immunoglobulin-like type I inhibitory
receptors — such as the human killer cell inhibitory
receptor (KIR) and the mouse gp49B glycoprotein — and
lectin-like type II inhibitory receptors — such as the
human CD94/NKG2 heterodimer and the mouse Ly-49
receptor family [1]. These receptors use tyrosine
phosphorylation motifs in their cytoplasmic tails to
deliver a dominant-negative signal by recruiting the
tyrosine phosphatase SHP-1 [3–5]. We have identified a
new family of monocyte/macrophage immunoglobulin-
like receptors (MIRs) related to KIR. Two cDNA clones
with sequence similarity to each other and to the gp49B
gene were isolated from human lymphocytes; both
encode proteins containing four immunoglobulin
domains and the conserved cytoplasmic inhibitory
motifs, and transcription of both was detected primarily
in monocytes/macrophages, rather than T, NK, or mast
cells. The MIR genes are closely linked to the KIR gene
family and the gene for FcαR on chromosome 19, at
cytogenetic band q13.4. A mouse sequence related to
MIR was mapped to a region on mouse chromosome 7
syntenic with human 19q13.4. Our findings should
facilitate studies of the evolution and function of the
MIR and KIR families.
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Results and discussion
We investigated whether gp49B-related sequences are
expressed in human lymphocytes. A search of human
expressed sequence tags (ESTs) revealed a 215 bp EST
(GenBank accession number T73907) which encodes a
stretch of 52 amino acids with 46% sequence identity to
gp49B [6]. A larger fragment (clone-4) extending this EST
was amplified by 5′ rapid amplification of cDNA ends
(RACE) using the polymerase chain reaction (PCR), and
used to screen a human lymphocyte cDNA library. Two
clones, cl-7 and cl-10, were sequenced completely
(GenBank accession numbers AF004230 and AF004231).
The nucleotide sequences of the three cDNAs are
74–83% identical to each other; cl-7 and cl-10 encode type
I transmembrane proteins with four immunoglobulin
domains of the C-2 type, transmembrane regions of
23 amino acids, and cytoplasmic tails of 168 and 115 amino
acids, respectively. The amino-terminal immunoglobulin
domains of the cl-7 and cl-10 proteins are most closely
related to regions of mouse gp49B (41–43% identity).
GenBank searches with the extracellular portion of the
mature proteins indicated, however, that the newly
described p91 or PIR (paired immunoglobulin-like recep-
tor) mouse protein, which contains six immunoglobulin
domains [7,8], is the closest relative (63% identity with the
third immunoglobulin domain of the cl-7 protein). The
next closest relatives of the proteins encoded by cl-7 and
cl-10 are bovine Fcγ2R and human KIR.
The cytoplasmic tails of the cl-7 and cl-10 proteins contain
tyrosine phosphorylation motifs similar to those in several
Figure 1
KIR   HRWCSNKKKNAAV............14.............DSDEQDPQEVTYAQLDHCVF..14..PPTDTIVYTELPNA..10..
gp49B   GYQYGHKKKANAS..19..EDPQGIVYAQVKPSR..3...DTACKETQDVTYAQLCIRTQ..5..
p91   .44.QEESLYASV..19..EDPQGETYAQVKPSR..33..AAESGESQDVTYAQLCSRTL..14..APEEPSVYATLAAA..11..
cl-7   .44.QEENLYAAV..18..EDPQAVTYAEVKHSR..33..AAASEAPQDVTYAQLHSLTL..14..SPAVPSIYATLAIH
cl-10   .44.QEENLYAAV............14.............AAASEAPQDVTYAQLHSLTL..14..PPAEPSIYATLAIH
The cytoplasmic tails of the proteins encoding cl-7 and cl-10 share
conserved sequence motifs with inhibitory receptors. Amino-acid
sequences of the cl-7 and cl-10 cytoplasmic tails were aligned with
those of mouse p91/PIR, human KIR, and mouse gp49B inhibitory
receptors. Dark and light shading indicate identity between and within
the two groups of receptors, respectively. The complete cytoplasmic
tails are shown, with the spaces between conserved regions given as
numbers of amino acids.
receptors known to have inhibitory functions, including
KIR, gp49B, Ly-49, and NKG2 [3,5,6,9,10]. Notably, the
cytoplasmic tails of the cl-7 and cl-10 proteins contain the
amino-acid sequence QDVTYAQL (in single letter code)
found in the mouse NK inhibitory receptor gp49B and in
the p91/PIR molecule (Figure 1). Members of the KIR
family contain the sequence QEVTYAQL and a second,
related, tyrosine phosphorylation motif with the consensus
sequence V/IxYxxL, in which x is any amino acid
(Figure 1). Phosphotyrosine residues in these motifs
recruit and activate the tyrosine phosphatase SHP-1
[3,9,11], which is crucial to the inhibition of NK-mediated
lysis [3]. The specificity of the binding of SHP-1 to phos-
phorylated KIR is determined by residues around the tyro-
sine, with the amino acid at position –2 being particularly
important [12]. The presence of the conserved
QDVTYAQL motif in the cl-7 and cl-10 proteins, and of an
additional VxYxxV motif in the cl-7 protein, suggests that
these proteins are inhibitory receptors. Additional
sequence conservation in the cytoplasmic tails of these
receptors is evident (Figure 1). Recently, a related mole-
cule (ILT3) that has two immunoglobulin domains was
shown to inhibit macrophage activation when co-ligated
with stimulatory receptors [13].
The cl-7 and cl-10 proteins have unusually long stems, of
about 30 amino acids, connecting the membrane-proximal
immunoglobulin domain to the transmembrane region.
KIR, p91, and gp49B have stem regions of 17, 16, and
13 amino acids, respectively. Remarkably, about 50% of
the stem of KIR, p91, cl-7 and cl-10 is composed of pro-
lines or serines. These stems, which are absent from the
related but non-inhibitory FcαR and Fcγ2R receptors, con-
tribute to the definition of a new subfamily of inhibitory
receptors within the immunoglobulin superfamily.
Hybridization of a cl-7 probe to a northern blot of human
tissues revealed multiple mRNA species primarily in
peripheral blood lymphocytes (PBLs) and lung (data not
shown). Freshly isolated PBLs were sorted using specific
monoclonal antibodies and magnetic separation, and RNA
was extracted from each subset. Comparison of resting
CD19+ B cells, CD3+ T cells, CD3– NK cells and CD14+
monocytes revealed that the CD14+ subset accounted for
most of the hybridization signal (Figure 2a). CD14+ cells
in the periphery are primarily monocytes but this class also
includes macrophages and some dendritic cells. Weak
hybridization signals were detected in other subsets of
cells on longer exposures; these signals may represent
either low-level expression or contamination of the
subsets by monocytes. 
The cl-7 probe hybridized to mRNA from several mono-
cytic and B cell lines, and from the NK cell lines NK3.3
and NK-92 (Figure 2b). Sequences (called ILT1 and
ILT2) related to cl-7 and cl-10 were recently described
that are expressed in several cell lines of the monocytic,
NK, and B-cell lineages [14]. As shown here with normal
cells isolated from peripheral blood, however, a strong
hybridization signal with cl-7 was detected in the CD14+
subset, but not in either resting or activated T cells or NK
cells. Furthermore, using a PCR assay, cl-7 or cl-10
expression was detected in only one out of 23 randomly
selected NK clones (data not shown), supporting the con-
clusion that CD3– NK cells generally do not express cl-7
or cl-10 sequences. A single-strand conformation polymor-
phism assay was used to show that sequences correspond-
ing to cl-7 and cl-10 were expressed in the CD14+
populations (data not shown). We conclude from our data
that sequences corresponding to cl-7 and cl-10 are prefer-
entially expressed in cells of the monocytic lineage; we
therefore refer to them as monocyte/macrophage
immunoglobulin-like receptors (MIRs).
On Southern blots, the cl-7 probe cross-hybridized at inter-
mediate stringency (2× SSC, 68°C) with a few fragments in
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Figure 2
The cl-7 and cl-10 genes are preferentially
expressed in monocytes. (a) Northern blot of
RNA isolated from the indicated subsets of
resting or activated cells (3 weeks in
100 units per ml rIL-2), purified by incubation
with antibodies conjugated to magnetic beads
and separation on MACS columns (Miltenyi
Biotec). The probe was a fragment containing
most of the coding region of cl-7. The final
wash was in 0.2× SSC at 68°C. (b) Northern-
blot analysis of cl-7 expression in the
indicated human cell lines using the same
probe as in (a). The final wash was in 2× SSC
at 68°C.
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mouse genomic DNA (data not shown). This result con-
trasts with results using the mouse gp49B gene and human
KIR genes, which do not cross-hybridize to sequences in
the other species, even at low stringency. Human MIRs
and mouse p91/PIR have 68% nucleotide identity over a
741 bp stretch. A mouse p91 probe hybridized to the same
bands in mouse DNA and to a subset of the bands in
human DNA as hybridized with cl-7 (data not shown). The
cl-7 probe hybridized to several fragments in human DNA
digested with various enzymes, indicating that there is a
small family of genes related to cl-7 (data not shown),
which would be consistent with the fact that a number of
MIR cDNA clones — corresponding to five genes — have
been described so far (this study and [13,14]).
Human KIR family genes are located on chromosome 19,
within the q13.4 region [15]. PCR analysis of DNA
derived from a panel of hamster/human cell lines showed
that the MIR sequences are also on chromosome 19 (data
not shown). The exact location of KIR and MIR genes
was determined by hybridization to arrayed cosmids
derived from chromosome 19; both KIR and MIR genes
mapped to cosmids in contigs which had previously been
mapped to 19q13.4 [16]. The MIR genes were cen-
tromeric relative to the KIR genes, which in turn were
centromeric relative to the gene for FcαR (FCAR;
Figure 3). The genes encoding the MIRs, KIRs and FcαR
map within approximately 600 kb and define a new gene
complex encoding structurally related receptors.
The failure to identify mouse KIR gene homologs has long
been an enigma. The linkage of the human MIR and KIR
genes, and the existence of the MIR-related mouse
p91/PIR sequences gave us an opportunity to test whether
there is a mouse genomic region syntenic to the human
genomic region containing the MIR genes. A genomic
p91/PIR bacterial artificial chromosome (BAC) clone was
isolated and used to determine the chromosomal location
by fluorescent in-situ hybridization (FISH) mapping. The
results revealed that p91/PIR sequences are located on
band A2 of mouse chromosome 7 (Figure 4), in agreement
with a recent report [8]. Another gene mapped to 7A2 using
FISH is Clc4-2, which is 4 cM from the centromere (Mouse
Genome Database at http://www.informatics.jax.org).
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Figure 3
Physical linkage of MIR and KIR genes.
Diagram of the physical metric map of human
chromosome 19q13.4 showing the location of
the MIR, KIR, and FCAR genes. Indicated
distances are from the centromere–19q
euchromatin boundary (in Mb). FISH,
fluorescent in situ hybridization; BAC,
bacterial artificial chromosome.
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Figure 4
Mouse p91 genes map to a chromosomal region that is syntenic to the
human region encoding MIRs and KIRs. The region of mouse
chromosome 7 that contains Pkcc and Syt3 is inverted relative to the
rest of the synteny between mouse chromosome 7 and human
chromosome 19. Distances from the centromere are indicated in cM
(mouse) or Mb (human).
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Interestingly, the PRKCG and SYT3 genes that flank the
human MIR–KIR–FCAR gene complex have orthologs on
mouse chromosome 7 [17], near Clc4-2. This region on
mouse chromosome 7 is syntenic with the human 19q13.4
region [17], which contains the KIR–MIR gene complex. It
is therefore likely that the mouse p91/PIR genes map
between Pkcc and Syt3.
The family of type I transmembrane, immunoglobulin-
like inhibitory receptors has been expanded by the identi-
fication of the MIR genes expressed in human monocytes.
This receptor family now comprises the human KIR and
MIR and the mouse gp49B and p91/PIR molecules.
These receptors all have conserved tyrosine phosphoryla-
tion motifs in their cytoplasmic tails which have been
implicated in negative signaling. Effector cells of the
innate immune system, such as mast cells, monocytes and
macrophages, and NK cells, may all be negatively regu-
lated by such inhibitory receptors. 
Materials and methods
Isolation of cDNA clones and hybridization
The oligonucleotide 5′-AGAATGAAGCCGCCAAATGCCAC, specific for
nucleotides 116–138 of the EST yc54d09.r1 (GenBank accession
number T73907), was used as reverse PCR primer in a 5′ RACE reaction
containing human PBL cDNA and the forward adapter primer AP1 (Clon-
tech). This resulted in a 576 bp PCR product called clone-4 (GenBank
accession number U70665) [6]. Clone-4 was used to screen a cDNA
library made from resting human PBLs (Life Technologies) at high strin-
gency. Two clones (cl-7 and cl-10) with intact open reading frames were
completely sequenced. For hybridization, total RNA (5 µg per lane) from
human cell lines or from fresh, resting human PBLs or subsets of PBLs,
was separated on a 0.8% agarose/formaldehyde gel, transferred to a
Genescreen Plus filter using a pressure blotter (Stratagene), and probed
with a 32P-labeled Bgl I fragment (nucleotides 17–2112) of cl-7.
Chromosomal localizations
The MIR sequences were located to chromosome 19 by PCR analysis
using DNA from human/hamster somatic cell hybrids (Bios). The MIR and
KIR genes were assigned to cosmids by screening an 11× arrayed cosmid
library specific for chromosome 19 as previously described [18]. The physi-
cal map of chromosome 19 was created by analyzing cosmids using a fin-
gerprinting strategy [19,20]. Contigs were placed along the linear DNA
molecule and estimates of genomic distances were obtained by 2-color,
three-cosmid FISH analysis, as described [21,22]. In order to facilitate
closure of the gaps among the contigs containing members of the gene
family, long-range Alu PCR products [23] from cosmid templates were
hybridized against a human BAC library [24]. The extent of overlap of the
BAC clones with the previously identified cosmid contigs was confirmed by
hybridization and also by construction of an EcoRI restriction digest map as
described [16]. The overall strategy and a global view of the chromosome
19 metric physical map has been described [16]. An updated version of the
map is available at http://www-bio.llnl.gov/bbrp/genome/genome.html. The
chromosomal location of mouse p91/PIR was determined by FISH
(Genome Systems) using a genomic p91/PIR clone labeled with digoxi-
genin-conjugated dUTP. Observations of specifically hybridized chromo-
somes 7 demonstrated that p91 is located immediately adjacent to the
heterochromatic region in band 7A2. A total of 80 metaphase cells were
analyzed, with 64 exhibiting specific labeling.
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